Probiotics for the prevention of antibiotic-associated diarrhea and Clostridium difficile infection among hospitalized patients: Systematic review and meta-analysis

Open Medicine

Volumn 7, Issue 2, 2013, Pages 1-12

  Pattani, Reena ^a,c   Palda, Valerie A ^b   Hwang, Stephen W ^c   Shah, Prakeshkumar S ^d  

^a UNIVERSITY OF TORONTO   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c ST MICHAEL'S HOSPITAL   (Canada)

^d UNIVERSITY OF TORONTO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84885103912     PISSN: None     EISSN: 19112092     Source Type: Journal    
DOI: None     Document Type: Review

References (40)

1. Valiquette L, Low DE, Pépin J, McGeer A. Clostridium difficile infection in hospitals: a brewing storm. CMAJ 2004;171(1):27-29.
2. Hurley BW, Nguyen CC. The spectrum of pseudomembranous enterocolitis and antibiotic-associated diarrhea. Arch Intern Med 2002;162(19):2177-2184.
3. Bauer MP, van Dissel JT. Alternative strategies for Clostridium difficile infection. Int J Antimicrob Agents 2009;33 Suppl 1:S51-S56.
4. Bartlett JG. A call to arms: the imperative for antimicrobial stewardship. Clin Infect Dis 2011;53 Suppl 1:S4-S7.
5. Cremonini F, Di Caro S, Nista EC, Bartolozzi F, Capelli G, Gasbarrini G, et al. Meta-analysis: the effect of probiotic administration on antibiotic- associated diarrhoea. Aliment Pharmacol Ther 2002;16(8):1461-1467.
6. McFarland LV. Meta-analysis of probiotics for the prevention of antibiotic associated diarrhea and the treatment of Clostridium difficile disease. Am J Gastroenterol 2006;101(4):812-822.
7. Dendukuri N, Costa V, McGregor M, Brophy JM. Probiotic therapy for the prevention and treatment of Clostridium difficile-associated diarrhea: a systematic review. CMAJ 2005;173(2):167-170.
8. Hempel S, Newberry SJ, Maher AR, Wang Z, Miles JNV, Shanman R, et al. Probiotics for the prevention and treatment of antibioticassociated diarrhea: a systematic review and meta-analysis. JAMA 2012;307(18):1959-1969.
9. Johnson S, Maziade PJ, McFarland LV, Trick W, Donskey C, Currie B, et al. Is primary prevention of Clostridium difficile infection possible with specific probiotics? Int J Infect Dis 2012;16(11):e786-e792.
10. Loo VG, Bourgault A, Poirier L, Lamothe F, Michaud S, Turgeon N, et al. Host and pathogen factors for Clostridium difficile infection and colonization. N Engl J Med 2011;365(18):1693-1703.
11. Moher D, Liberati A, TetzlaffJ, Altman DG; PRISMA Group. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Open Med 2009;3(3):e123-e130.
12. Harris RP, Helfand M, Woolf SH, Lohr KN, Mulrow CD, Teutsch SM, et al.; Methods Work Group, Third US Preventive Services Task Force. Current methods of the US Preventive Services Task Force: a review of the process. Am J Prev Med 2001;20(3 Suppl):21-35.
13. Gao XW, Mubasher M, Fang CY, Reifer C, Miller LE. Dose-response efficacy of a proprietary probiotic formula of Lactobacillus acidophilus CL1285 and Lactobacillus casei LBC80R for antibiotic-associated diarrhea and Clostridium difficile-associated diarrhea prophylaxis in adult patients. Am J Gastroenterol 2010;105(7):1636-1641.
14. Hickson M, D'Souza AL, Muthu N, Rogers TR, Want S, Rajkumar C, et al. Use of probiotic Lactobacillus preparation to prevent diarrhoea associated with antibiotics: randomised double blind placebo controlled trial. BMJ 2007;335(7610):80.
15. Beausoleil M, Fortier N, Guénette S, L'Ecuyer A, Savoie M, Franco M, et al. Effect of a fermented milk combining Lactobacillus acidophilus Cl1285 and Lactobacillus casei in the prevention of antibioticassociated diarrhea: a randomized, double-blind, placebo-controlled trial. Can J Gastroenterol 2007;21(11):732-736.
16. McFarland LV, Surawicz CM, Greenberg RN, Elmer GW, Moyer KA, Melcher SA, et al. Prevention of beta-lactam-associated diarrhea by Saccharomyces boulardii compared with placebo. Am J Gastroenterol 1995;90(3):439-448.
17. Sampalis J, Psaradellis E, Rampakakis E. Efficacy of BIO K+ CL1285 in the reduction of antibiotic-associated diarrhea-a placebo controlled double-blind randomized, multi-center study. Arch Med Sci 2010;6(1):56-64.
18. Song HJ, Kim JY, Jung SA, Kim SE, Park HS, Jeong Y, et al. Effect of probiotic Lactobacillus (Lacidofil® cap) for the prevention of antibiotic- associated diarrhea: a prospective, randomized, double-blind, multicenter study. J Korean Med Sci 2010;25(12):1784-1791.
19. Plummer S, Weaver MA, Harris JC, Dee P, Hunter J. Clostridium difficile pilot study: effects of probiotic supplementation on the incidence of C. difficile diarrhoea. Int Microbiol 2004;7(1):59-62.
20. Thomas MR, Litin SC, Osmon DR, Corr AP, Weaver AL, Lohse CM. Lack of effect of Lactobacillus GG on antibiotic-associated diarrhea: a randomized, placebo-controlled trial. Mayo Clin Proc 2001;76(9):883-889.
21. Lewis SJ, Potts LF, Barry RE. The lack of therapeutic effect of Saccharomyces boulardii in the prevention of antibiotic-related diarrhoea in elderly patients. J Infect 1998;36(2):171-174.
22. Pozzoni P, Riva A, Bellatorre A, Amigoni M, Redaelli E, Ronchetti A, et al. Saccharomyces boulardii for the prevention of antibioticassociated diarrhea in adult hospitalized patients: a single-center, randomized, double-blind, placebo-controlled trial. Am J Gatroenterol 2012;107(6):922-931.
23. Cimperman L, Bayless G, Best K, Diligente A, Mordarski B, Oster M, et al. A randomized, double-blind, placebo-controlled pilot study of Lactobacillus reuteri ATCC 55730 for the prevention of antibiotic- associated diarrhea in hospitalized adults. J Clin Gastroenterol 2011;45(9):785-789.
24. Wenus C, Goll R, Loken EB, Biong AS, Halvorsen DS, Florholmen J. Prevention of antibiotic-associated diarrhoea by a fermented probiotic milk drink. Eur J Clin Nutr 2008;62(2):299-301.
25. Can M, Besirbellioglu BA, Avci IY, Beker CM, Pahsa A. Prophylactic Saccharomyces boulardii in the prevention of antibiotic-associated diarrhea: a prospective study. Med Sci Monit 2006;12(4):PI19-PI22.
26. Surawicz CM, Elmer GW, Speelman P, McFarland LV, Chinn J, van Belle G. Prevention of antibiotic-associated diarrhea by Saccharomyces boulardii: a prospective study. Gastroenterology 1989;96(4):981-988.
27. Wunderlich PF, Braun L, Fumagalli I, D'Apuzzo V, Heim F, Karly M, et al. Double-blind report on the efficacy of lactic acid-producing Enterococcus SF68 in the prevention of antibiotic-associated diarrhoea and in the treatment of acute diarrhoea. J Int Med Res 1989;17(4):333-338.
28. Gotz V, Romankiewicz JA, Moss J, Murray HW. Prophylaxis against ampicillin-associated diarrhea with a lactobacillus preparation. Am J Hosp Pharm 1979;36(6):754-757.
29. Bengmark S. Ecological control of the gastrointestinal tract: the role of probiotic flora. Gut 1998;42(1):2-7.
30. Kelly C, Pothoulakis C, LaMont JT. Clostridium difficile colitis. N Engl J Med 1994;330(4):257-262.
31. Rautio M, Jousimies-Somer H, Kauma H, Pietarinen I, Saxelin M, Tynkkynen S, et al. Liver abscess due to a Lactobacillus rhamnosus strain indistinguishable from L. rhamnosus strain GG. Clin Infect Dis 1999;28(5):1159-1160.
32. Mackay AD, Taylor MB, Kibbler CC, Hamilton-Miller JM. Lactobacillus endocarditis caused by a probiotic organism. Clin Microbiol Infect 1999;5(5):290-292.
33. Luong M, Sareyyupoglu B, Nguyen MH, Silveira FP, Shields RK, Potoski BA, et al. Lactobacillus probiotic use in cardiothoracic transplant recipients: a link to invasive Lactobacillus infection? Transpl Infect Dis 2010;12(6):561-564.
34. Gareau MG, Sherman PM, Walker WA. Probiotics and the gut microbiota in intestinal health and disease. Nat Rev Gastroenterol Hepatol 2010;7(9):503-514.
35. QuickStats: rates of Clostridium difficile infection among hospitalized patients aged = 65 by age group-National Hospital Discharge Survey, United States, 1996-2009. MMWR 2011;60(34):1171. Available from: www.cdc.gov/mmwr/preview/mmwrhtml/mm6034a7.htm?s_ cid=mm6034a7_w (accessed 2012 Dec. 1).
36. Cober ED, Malani PN. Clostridium difficile infection in the "oldest" old: clinical outcomes in patients aged 80 and older. J Am Geriatr Soc 2009;57(4):659-662.
37. Serrano PE, Khuder SA, Fath JJ. Obesity as a risk factor for nosocomial infections in trauma patients. J Am Coll Surg 2010;211(1):61-67.
38. Stein GY, Nanim R, Karniel E, Moskowitz I, Zeidman A. [Probiotics as prophylactic agents against antibiotic-associated diarrhea in hospitalized patients]. Harefuah 2007;146(7):520-522, 575. Article in Hebrew.
39. Cots JM. [Consumption of probiotics can reduce the incidence of antibiotic-associated diarrhea]. Form Med Contin Aten Prim 2008;15(3):201. Article in Spanish.
40. Li D, Wang H, Tan M, Shao Y. [Use of probiotics for prevention of antibiotic- associated diarrhea in elderly patients]. Chin J Gastroenterol 2010;15(3):154-156. Article in Chinese.